Company Synairgen plc CINNOBER BOAT
Equities
SNG
GB00B0381Z20
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Richard Marsden
CEO | Chief Executive Officer | 57 | 03-10-31 |
Joseph Colliver
DFI | Director of Finance/CFO | 43 | 11-05 |
Marcin Mankowski
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-02 |
Jody Brooks
CTO | Chief Tech/Sci/R&D Officer | - | 04-01-31 |
Phillip Monk
CTO | Chief Tech/Sci/R&D Officer | 55 | 06-09-30 |
Richard Hennings
PRN | Corporate Officer/Principal | - | 21-02-28 |
Helen Gearing
PRN | Corporate Officer/Principal | - | 21-11-30 |
Gareth Walters
LAW | General Counsel | - | 21-10-12 |
Richard Francis
PRN | Corporate Officer/Principal | - | 21-08-31 |
Simon Holden
SEC | Corporate Secretary | 48 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Shaw
CHM | Chairman | 59 | 03-05-31 |
Stephen Holgate
FOU | Founder | 77 | 03-05-31 |
Richard Marsden
CEO | Chief Executive Officer | 57 | 03-10-31 |
David Campbell
BRD | Director/Board Member | 80 | 06-04-10 |
Felicity Gabbay
BRD | Director/Board Member | 72 | 22-09-28 |
Phillip Monk
CTO | Chief Tech/Sci/R&D Officer | 55 | 06-09-30 |
Amanda Radford
BRD | Director/Board Member | 53 | 22-11-30 |
Joseph Colliver
DFI | Director of Finance/CFO | 43 | 11-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 201,374,975 | 195,153,037 ( 96.91 %) | 0 | 96.91 % |
Company contact information
Synairgen Plc
Mailpoint 810 Southampton General Hospital
SO16 6YD, Southampton
+44 23 8051 2800
http://www.synairgen.comSector
1st Jan change | Capi. | |
---|---|---|
+22.81% | 46.81B | |
+46.56% | 41.29B | |
-1.88% | 41.37B | |
-6.20% | 28.87B | |
+11.33% | 26.06B | |
-21.00% | 19.13B | |
-1.43% | 11.96B | |
+30.73% | 12.39B | |
-0.48% | 12.08B |